The efficacy of rHuEPO in cancer-related anaemia.
Samol
Jens
J
Department of Haematology, John Radcliffe Hospital, Oxford, UK.
Littlewood
Timothy J
TJ
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D001803:Blood Transfusion; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000150:complications*; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000150:complications / Q000188:drug therapy; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000188:drug therapy; D011379:Prognosis; D011788:Quality of Life; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000209:etiology; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin